Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcomes of thalidomide in refractory Crohn's disease.
Gerich ME, Yoon JL, Targan SR, Ippoliti AF, Vasiliauskas EA. Gerich ME, et al. Among authors: ippoliti af. Aliment Pharmacol Ther. 2015 Mar;41(5):429-37. doi: 10.1111/apt.13057. Epub 2014 Dec 15. Aliment Pharmacol Ther. 2015. PMID: 25511905 Free article.
A pilot study of adalimumab in infliximab-allergic patients.
Youdim A, Vasiliauskas EA, Targan SR, Papadakis KA, Ippoliti A, Dubinsky MC, Lechago J, Paavola J, Loane J, Lee SK, Gaiennie J, Smith K, Do J, Abreu MT. Youdim A, et al. Among authors: ippoliti a. Inflamm Bowel Dis. 2004 Jul;10(4):333-8. doi: 10.1097/00054725-200407000-00002. Inflamm Bowel Dis. 2004. PMID: 15475739 Clinical Trial.
Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease.
Spivak J, Landers CJ, Vasiliauskas EA, Abreu MT, Dubinsky MC, Papadakis KA, Ippoliti A, Targan SR, Fleshner PR. Spivak J, et al. Among authors: ippoliti a. Inflamm Bowel Dis. 2006 Dec;12(12):1122-30. doi: 10.1097/01.mib.0000235833.47423.d7. Inflamm Bowel Dis. 2006. PMID: 17119386 Clinical Trial.
224 results